New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor of Urologic Oncology at the University of Utah, and leading urologic oncologists Dr. Mark Tyson from Mayo Clinic Arizona and Dr. Suzanne Merrill from Colorado Urology.
---
This podcast is supported by:
Ferring Pharmaceuticals
https://www.ferring.com/home-classic/people-and-families/uro-uro-oncology/bladder-cancer/
---
SYNPOSIS
The discussion delves into the newest treatment strategies and FDA-approved therapies for non-muscle invasive bladder cancer with an emphasis on BCG-refractory patients. They highlight their approaches to sequencing therapies, the real-world applicability of these treatments, and the impact of patient factors in clinical decision-making. The panel also explores emerging trials and innovative treatment mechanisms, emphasizing the importance of personalized care in oncology.
---
TIMESTAMPS
00:00 - Introduction
05:09 - Challenges and Strategies in Treatment
10:55 - Bladder Sparing Therapies
21:41 - Practical Tips for Therapy Administration
30:39 - Challenges and Considerations in Reinduction
37:05 - Clinical Trials and Future Directions
44:11 - Counseling Patients on Treatment Options
57:36 - Concluding Thoughts and Future Outlook
---
RESOURCES
CORE-008 Clinical Trial
https://www.sciencedirect.com/science/article/abs/pii/S1078143924010147
Legend Clinical Trial:
https://ascopubs.org/doi/10.1200/JCO.2025.43.5_suppl.802
CISTO Study
https://pubmed.ncbi.nlm.nih.gov/37980511/

When a patient is diagnosed with non-muscle invasive bladder cancer (NMIBC), how do you tailor the conversation and treatment plan to their individual needs (and fears)? In part two of the 2025 NMIBC Creator Weekend™ series, host Dr. Vignesh Packiam is joined by Dr. Sima Porten from UCSF and Dr. Patrick Hensley from the University of Kentucky to discuss patient-centered diagnostic and therapeutic approaches for non-muscle invasive bladder cancer.
---
This podcast is supported by:
Ferring Pharmaceuticals
https://www.ferring.com/home-classic/people-and-families/uro-uro-oncology/bladder-cancer/
---
SYNPOSIS
The conversation covers initial patient consultations, discussing diagnoses, personalized treatment options such as BCG, gemcitabine, clinical trials, and managing side effects. The experts emphasize the importance of clear communication, understanding patient preferences, and tailoring approaches to enhance the patient's quality of life. They also explore insights from recent studies like the CISTO trial and highlight novel research directions.
---
TIMESTAMPS
00:00 - Introduction
04:28 - Counseling Patients on Diagnostic Findings
12:03 - Symptom Management and Patient Care
19:30 - Post-Procedure Care and Counseling
28:50 - Recovery After TURBT: Medications and Patient Care
44:16 - The Impact of Radical Cystectomy on Quality of Life
49:15 - Final Thoughts and Future Directions in Bladder Cancer Care
---
RESOURCES
NIMBUS Study
https://pubmed.ncbi.nlm.nih.gov/32446864/

For patients with ischemic priapism, time to treatment can mean the difference between recovery and long-term dysfunction. In this episode, Dr. Maia VanDyke (UT Southwestern Medical Center) joins host Dr. Juan Andino (UCLA Health) for a high-yield discussion on managing this urologic emergency, from early recognition to advanced surgical options.
---
SYNPOSIS
Together, they cover diagnosis, patient demographics, and traditional versus advanced interventions, with special attention to the role of penoscrotal decompression in prolonged ischemic priapism. The conversation highlights surgical techniques, postoperative care strategies, and patient counseling, including the hard but essential discussions about long-term erectile dysfunction risk. Drs. Andino and VanDyke also emphasize the importance of collaboration, encouraging general urologists to adopt these approaches while leaning on colleagues and centers of excellence for complex cases.
---
TIMESTAMPS
00:00 - Introduction
02:18 - Understanding Priapism
07:52 - Diagnosis and Initial Management
16:51 - Advanced Management and Surgical Interventions
28:21 - Patient Retention Challenges
29:59 - Surgical Planning and Techniques
37:29 - Post-Operative Care and Patient Rehabilitation
44:13 - Future Directions in Research and Treatment
51:28 - The Role of General Urology
---
RESOURCES
Dr. David Ralph article on use of MRI in management of priapism
https://doi.org/10.1111/j.1464-410X.2010.09368.x
Dr. Tom Lue article on corporal aspiration
https://doi.org/10.1038/nrurol.2009.50
Arthur “Bud” Burnett article on corporal tunneling
https://doi.org/10.1016/j.juro.2012.08.245
Allen “Al” Morey article on penoscrotal decompression erectile function outcomes
https://doi.org/10.1111/bju.15127
Survey on current management practices of ischemic priapism
https://doi.org/10.1038/s41443-019-0120-4
Risk factors, diagnosis, and long-term erectile dysfunction outcomes in priapism
https://doi.org/10.1038/s41443-025-01076-9
Video Journal of Sexual Medicine (VJSM) on Penoscrotal decompression: A better method for priapism management
https://www.vjsm.info/videos/all/penoscrotal-decompression-a-better-method-for-priapism-management
Surgical Management of Ischemic Priapism: what are the New Options? https://doi.org/10.1590/S1677-5538.IBJU.2024.0497
The Impact of Immediate Salvage Surgery on Corporeal Length Preservation
https://doi.org/10.1016/j.juro.2018.01.082

How are leading urologic oncologists using advanced biomarkers and artificial intelligence to refine the diagnosis and management of non-muscle invasive bladder cancer (NMIBC)? In the opening episode of our 2025 NMIBC Creator Weekend™ series, host Dr. Bogdana Schmidt engages in an insightful, in-studio discussion with Dr. Anne Schuckman and Dr. Piyush Agarwal about contemporary strategies and challenges in the diagnosis of non-muscle invasive bladder cancer.

---

This podcast is supported by:

Ferring Pharmaceuticals

---

SYNPOSIS

The doctors emphasize the importance of having an experienced cytopathologist and discuss the use of different biomarkers and imaging modalities in bladder cancer diagnosis. The conversation delves into risk stratification, patient management strategies, and the evolving role of technology and artificial intelligence in enhancing diagnostic accuracy. The experts also share their perspectives on future advancements and their potential impact on clinical practice.

---

TIMESTAMPS

00:00 - Introduction
04:05 - Surveillance and Follow-Up Strategies
10:10 - Biomarkers in Bladder Cancer
18:02 - Blue Light Cystoscopy and Patient Comfort
30:56 - Risk Assessment and Counseling
42:56 - Future of Bladder Cancer Diagnostics
47:00 - Concluding Thoughts

---

RESOURCES

CxBladder Study
https://www.sciencedirect.com/science/article/pii/S1078143923000091

Lars Dyrsakjot Study on Tumor Markers
https://pmc.ncbi.nlm.nih.gov/articles/PMC7690647/

The Bridge Trial
https://pmc.ncbi.nlm.nih.gov/articles/PMC10515442/

Kidney cancer management is evolving. How are experts adapting? In this installment of BackTable Tumor Board, Dr. Brandon Manley (Urologic Oncology, Moffitt Cancer Center), Dr. Raquibul Hannan (Radiation Oncology, UT Southwestern), and Dr. Rana McKay (Medical Oncology, UC San Diego) join guest host Mark Ball (Urologic Oncology, National Cancer Institute) to share their multidisciplinary perspectives on challenging, real-world kidney cancer cases.
---
This podcast is supported by:
Ferring Pharmaceuticals
https://ad.doubleclick.net/ddm/trackclk/N2165306.5658203BACKTABLE/B33008413.420220578;dc_trk_aid=612466359;dc_trk_cid=234162109;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;gdpr=${GDPR};gdpr_consent=${GDPR_CONSENT_755};gpp=${GPP_STRING_755};gpp_sid=${GPP_SID};ltd=;dc_tdv=1
---
SYNPOSIS
The conversation covers diagnostic dilemmas, navigating the treatment options of surgery, systemic therapy, and radiation, and the importance of a multidisciplinary approach. Through detailed case reviews, the panel highlights practical pearls, emerging clinical trials, and collaborative approaches that exemplify modern kidney cancer care.
---
TIMESTAMPS
0:00 - Introduction
02:20 - Case 1 (Incidental Renal Mass)
16:52 - Case 2 (Bilateral Renal Masses)
37:22 - Case 3 (Locally Advanced Renal Mass)
56:34 - Case 4 (Symptomatic, Metastatic Disease)
01:14:00 - Final Takeaways

What is the role of the American Medical Association (AMA) in 2025 and how does it affect your practice? Join Dr. Ruchika Talwar in this insightful episode of the BackTable Urology podcast as she converses with Dr. Willie Underwood, a urologic oncologist and president-elect of the American Medical Association.
---
SYNPOSIS
Dr. Underwood shares his journey into medical advocacy, the pivotal role of the AMA in advancing healthcare, and the importance of physician engagement in legislative processes. The discussion highlights key issues such as Medicare and Medicaid reforms, physician burnout, and the implementation of technology in healthcare. This episode is a must-listen for anyone in the medical field who wants to understand the significance of collective efforts in improving patient care and the future of healthcare. Stay tuned to learn how you can make a difference in organized medicine.
---
TIMESTAMPS
00:00 - Introduction
04:01 - The Role of the AMA
08:33 - AMA's Legislative Actions
14:40 - Engaging with the AMA
17:57 - Balancing Diverse Physician Values
30:38 - Importance of Physician Participation and PACs
40:13 - Final Thoughts and Call to Action

Kids with kidney stones–how do you treat them, prevent recurrence, and provide effective longitudinal care? In this episode of BackTable Urology, Dr. Nicholas Kavoussi and Dr. Scott Sparks join co-hosts Dr. Arthi Hannallah and Dr. Niccolo Passoni for a high-yield discussion on pediatric and adolescent stone disease.
---
SYNPOSIS
Together, they explore best practices for managing complex kidney stones in children, surgical techniques like supine PCNL, and the use of novel technologies such as thulium lasers and suction sheaths. The doctors also address strategies to reduce procedural trauma, manage pain, and minimize infection risk. Beyond the OR, they emphasize the psychological toll of recurrent interventions and the importance of thoughtful counseling, patient education, and a multidisciplinary approach to help patients successfully transition into adult care.
---
TIMESTAMPS
00:00 - Introduction
03:06 - Managing Complex Cases Without PCNL
10:25 - Approach to Supine PCNL
18:21 - Balancing Surgical Risks
24:21 - Shared Decision-Making and Setting Expectations
33:16 - Minimizing Postoperative Pain
37:47 - Innovations in Technology
55:55 - Transitioning from Pediatric to Adult Urology

What does it take to build a successful reconstructive urology practice while balancing the worlds of academia and private practice? In this episode of BackTable Urology, reconstructive urologist Dr. Lucas Wiegand joins host Dr. Jose Silva to explore his career journey from training at the University of South Florida and fellowship at Washington University, to establishing his practice at Orlando Health.
---
SYNPOSIS
Dr. Wiegand shares insights on the evolution of robotic surgery, from laparoscopic to single-port systems, and how these advances have improved patient recovery and expanded the possibilities for outpatient care.
The conversation also dives into the shifting boundaries between academic and private practice, the growing demand for reconstructive urology, and practical advice for residents considering fellowship training. Dr. Wiegand emphasizes the enduring value of subspecialty education, the increasing recognition (and even financial premium) placed on fellowship training, and the importance of continuous learning, collaboration, and patient-centered care.
---
TIMESTAMPS
00:00 - Introduction
03:12 - Robotic Surgery in Urology
04:08 - Choosing a Fellowship
07:18 - Single Port Robotics
11:36 - Open vs. Robotic Surgery
24:33 - The Growing Demand for Urologic Care in Florida
27:53 - Building a Reconstructive Urology Practice
32:48 - The Role of Fellowship in Reconstructive Urology
36:46 - Staying Current and Engaged Post-Residency
42:19 - Final Thoughts and Contact Information

Could ongoing trials redefine the management of oligometastatic and advanced prostate cancer? In this installment of BackTable Tumor Board, leading prostate cancer experts Dr. Neeraj Agarwal, a medical oncologist from the University of Utah, and Dr. Tyler Seibert, a radiation oncologist from UC San Diego, join host Dr. Parth Modi to share their insights on the latest clinical trials and persistent challenges in managing prostate cancer.

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

The multidisciplinary discussion addresses clinical decision-making in active surveillance versus early intervention, the role of PSMA PET imaging in detection and treatment planning, and evolving strategies for metastatic and castration-resistant disease. They also evaluate the therapeutic potential of alpha emitters and radioligand therapies, consider the evidence behind treatment intensification and de-intensification, and explore how these approaches can be individualized to optimize patient outcomes.

---

TIMESTAMPS

0:00 - Introduction
1:48 - Active Surveillance in Low-Risk Prostate Cancer
7:08 - Molecular Testing and Risk Stratification
8:28 - Radiation Therapy Approaches
20:16 - PSA Recurrence and PSMA PET Scans
32:40 - The Role of ADT
37:15 - PSMA PET Scans
40:58 - Genetic Testing in High-Risk and Metastatic Prostate Cancer
46:54 - Treatment Intensification vs. De-Intensification Trials
55:59 - Castration-Resistant Prostate Cancer

When it comes to menopause care, the facts are better than the fears. In this Urology/OBGYN crossover episode of the BackTable Podcast, host Dr. Suzette Sutherland welcomes renowned urologist Dr. Rachel Rubin to explore various aspects of sexual health and hormone replacement therapy (HRT), particularly for menopausal women.
---
SYNPOSIS
Dr. Rachel Rubin shares her career journey, expertise in sexual health, and the critical role of hormone replacement therapy (HRT) in managing menopause. She addresses common challenges and misconceptions, particularly around estrogen use, by demystifying the Women’s Health Initiative studies and emphasizing the proven safety and benefits of systemic and vaginal HRT. Dr. Rubin offers practical guidance on prescribing estrogen, progesterone, testosterone, and DHEA, while highlighting her advocacy to remove outdated FDA black box warnings on vaginal estrogen. Through personal anecdotes and professional insights, she empowers practitioners with evidence-based strategies and underscores the importance of education and research in advancing women’s health.
---
TIMESTAMPS
00:00 - Introduction
03:41 - Challenges in Menopause Medicine
07:21 - Misconceptions and Risks of HRT
15:35 - Understanding Bioidentical Hormones
18:48 - WHI Studies and Their Impact
23:21 - Practical Guide to Prescribing HRT
33:47 - Understanding Estrogen Levels and Risks
36:04 - Debating Gels vs. Patches
37:51 - Concerns with Compounded Products and Pellets
38:50 - Patient Education and Meeting Them Where They Are
42:12 - Progesterone Benefits and Sensitivities
46:38 - Testosterone Therapy for Women
51:36 - The Importance of Lab Tests
55:39 - DHEA and Vaginal Health
57:14 - Advocacy for Accurate Hormone Therapy Information
01:00:05 - Conclusion and Final Thoughts
---
RESOURCES
The Peter Attia Drive episode with Dr. Rachel Rubin:
https://peterattiamd.com/rachelrubin/
FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women:
https://www.youtube.com/live/_2ZRlOivC5M?si=-Xynb_BmWz2sWf4m
Dr. Rachel Rubin’s Hormone Therapy for Early Adopters Course:
https://rachelrubinmd.thinkific.com/courses/MHTCME